PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,154,478 | +3.4% | 676,625 | +5.5% | 0.00% | – |
| Q2 2023 | $4,016,297 | +8.6% | 641,581 | -17.2% | 0.00% | – |
| Q1 2023 | $3,696,750 | -93.6% | 775,000 | -88.3% | 0.00% | -100.0% |
| Q4 2022 | $57,545,906 | +24.1% | 6,614,472 | +69.7% | 0.00% | -33.3% |
| Q3 2022 | $46,375,000 | -37.1% | 3,897,050 | -24.6% | 0.00% | -25.0% |
| Q2 2022 | $73,694,000 | +38.0% | 5,171,490 | +101.6% | 0.00% | +33.3% |
| Q1 2022 | $53,415,000 | +37.9% | 2,565,545 | +53.0% | 0.00% | +50.0% |
| Q4 2021 | $38,724,000 | -28.5% | 1,676,355 | -7.8% | 0.00% | -33.3% |
| Q3 2021 | $54,187,000 | +61.0% | 1,818,342 | +84.5% | 0.00% | +50.0% |
| Q2 2021 | $33,664,000 | +67.8% | 985,488 | +61.5% | 0.00% | +100.0% |
| Q1 2021 | $20,067,000 | +57.3% | 610,120 | +194.1% | 0.00% | 0.0% |
| Q4 2020 | $12,760,000 | – | 207,453 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 2,336,909 | $48,654,000 | 28.27% |
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $67,351,000 | 25.73% |
| OUP Management Co., LLC | 989,232 | $20,596,000 | 15.68% |
| Nextech Invest Ltd. | 1,385,807 | $28,853,000 | 8.24% |
| Boxer Capital, LLC | 3,498,636 | $72,842,000 | 3.74% |
| COWEN AND COMPANY, LLC | 1,261,529 | $26,265,000 | 2.53% |
| Orbimed Advisors | 6,855,423 | $142,730,000 | 2.31% |
| RTW INVESTMENTS, LP | 3,872,154 | $80,618,000 | 1.67% |
| PERSONAL CFO SOLUTIONS, LLC | 350,342 | $7,294,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 135,500 | $2,821,000 | 1.32% |